Phosphorylation‐Mediated Regulation of FBXO31 Stability Under Cellular Homeostasis
Source abstract
Abstract
Abstract The S‐phase kinase‐associated protein 1 (Skp1)‐Cullin‐F‐box protein E3 ligase adaptor F‐box‐only protein 31 (FBXO31) regulates genomic stability and cell signaling in normal, genotoxic, and tumor cells by recognizing and ubiquitinating multiple downstream substrates. The stability and role of FBXO31 may be regulated by specific residual modification. In this study, five FBXO31 phosphorylation sites are identified in HEK293T cells using biochemical and biological techniques. Liquid chromatography–tandem mass spectrometry identifies phosphorylated residues, including threonine‐28 and ‐37 and serine‐33, ‐400, and ‐523. The PyMOL crystal structure reveals the location of these residues on FBXO31 and assesses whether they interact with the reported kinases. Western blotting and fluorescence‐activated cell sorting demonstrate that the phosphorylation of Thr‐37 and Ser‐523 contributes to FBXO31 protein stabilization, which is further confirmed by cycloheximide experiments. The regulatory roles of Thr‐37 and Ser‐523 in FBXO31 stability are associated with variations in phosphorylation levels and degradation pathways. These results demonstrate that phosphorylation regulates FBXO31 turnover, and phosphorylation at Thr‐37 or Ser‐523 may help identify upstream kinases and enhance the understanding of the physiological role of FBXO31.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Kruppel-like factors research · Ubiquitin and proteasome pathways · Cancer-related gene regulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Gastroenterology The Second Xiangya Hospital of Central South University Changsha Hunan 410011 China
Research Center of Digestive Disease Central South University Changsha Hunan 410011 China
Clinical Research Center for Digestive Diseases in Hunan Province Changsha Hunan 410011 China
Center of Medical Research The Second Xiangya Hospital of Central South University Changsha Hunan 410011 China
Funding
Health Commission of Hunan Province · Natural Science Foundation of Hunan Province
References (29)
Show source-provided references
1. 10.1016/S0092-8674(00)80098-710.1016/S0092-8674(00)80098-7 ↗
2. 10.1038/onc.2016.26810.1038/onc.2016.268 ↗
3. 10.1038/nature0801110.1038/nature08011 ↗
4. 10.1007/s00439-014-1438-010.1007/s00439-014-1438-0 ↗
5. 10.1073/pnas.151092911210.1073/pnas.1510929112 ↗
6. 10.1038/s41586-024-08475-w10.1038/s41586-024-08475-w ↗
7. 10.1158/0008-5472.CAN-05-093610.1158/0008-5472.CAN-05-0936 ↗
8. 10.1016/j.jbc.2021.10125310.1016/j.jbc.2021.101253 ↗
9. 10.1016/j.lfs.2020.11827710.1016/j.lfs.2020.118277 ↗
10. 10.1038/s41467-025-56633-z10.1038/s41467-025-56633-z ↗
11. 10.1002/ijc.3104010.1002/ijc.31040 ↗
12. 10.7150/thno.3037210.7150/thno.30372 ↗
13. Huang H. L. · Am. J. Cancer Res. · 2015 · 5 · 1814
14. 10.1016/j.bbrc.2021.11.08210.1016/j.bbrc.2021.11.082 ↗
15. 10.1073/pnas.170595411510.1073/pnas.1705954115 ↗
16. 10.1074/mcp.M000153-MCP20110.1074/mcp.M000153-MCP201 ↗
17. 10.1073/pnas.170867711510.1073/pnas.1708677115 ↗
18. V.Lawana M. C.Korrapati H. M.Mehendale in (Ed.:P.Wexler) Academic Press Oxford2014 pp.114–118.
19. 10.1016/j.celrep.2012.07.00610.1016/j.celrep.2012.07.006 ↗
20. 10.1038/nmeth.251810.1038/nmeth.2518 ↗
21. 10.1038/349132a010.1038/349132a0 ↗
22. 10.1074/jbc.275.4.287710.1074/jbc.275.4.2877 ↗
23. 10.1038/3506003210.1038/35060032 ↗
24. 10.1128/MCB.22.22.7831-7841.200210.1128/MCB.22.22.7831-7841.2002 ↗
25. 10.1074/jbc.M110.10437210.1074/jbc.M110.104372 ↗
26. 10.1074/jbc.M114.56034210.1074/jbc.M114.560342 ↗
27. 10.1038/s41467-021-25411-y10.1038/s41467-021-25411-y ↗
28. 10.15252/emmm.20160731510.15252/emmm.201607315 ↗
29. 10.1073/pnas.85.21.797210.1073/pnas.85.21.7972 ↗